Entering text into the input field will update the search result below

Ra Medical stock soars 68% on FDA nod for DABRA 2 catheter while board continues strategic review

Jul. 05, 2022 7:22 AM ETCatheter Precision, Inc. (VTAK)By: Ravikash, SA News Editor

Headquarters of US Food and Drug Administration (FDA)

Grandbrothers/iStock Editorial via Getty Images

  • The U.S. Food and Drug Administration granted 510(k) clearance to Ra Medical Systems' (NYSE:RMED) DABRA 2.0 catheter as part of the DABRA Excimer Laser System.
  • The company said the the next-generation DABRA catheter has new features which

Recommended For You

Comments

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About VTAK

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VTAK--
Catheter Precision, Inc.
INBS--
Intelligent Bio Solutions Inc.
AVGR--
Avinger, Inc.
BJDX--
Bluejay Diagnostics, Inc.
RSLS--
ReShape Lifesciences Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.